The resurgence of pertussis in the United States has stimulated considerable public health interest in developing new vaccination strategies to improve control of pertussis. The purpose of this article is to review the US Food and Drug Administration's regulatory framework for the prelicensure clinical evaluation of preventive vaccines and the clinical approaches that have been used to demonstrate effectiveness of US-licensed vaccines containing an acellular pertussis component.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1093/infdis/jit532 | DOI Listing |
Publication Analysis
Top Keywords
clinical evaluation
8
food drug
8
pertussis
4
evaluation pertussis
4
pertussis vaccines
4
vaccines food
4
drug administration
4
administration regulatory
4
regulatory considerations
4
considerations resurgence
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!